相关实验视频
Updated: Jun 23, 2026

07:25
Transdermal Measurement of Glomerular Filtration Rate in Mice
Published on: October 21, 2018
21.8K
对cofilin-1与原发性IgA脏病预后的相关性分析
Ruo-Bei Zhao1, Yuan-Shan Xu1, Xiao-Hua Li1
1Department of Nephrology, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong Road, Nanning City, 530021, Guangxi Province, China.
BMC nephrology
|September 3, 2024
概括
尿中可菲林-1水平升高表明IgA脏病 (IgAN) 患者功能下降和不良结果的风险较高. 科菲林-1显示出作为预测IgAN进展的生物标志物的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物发现发现
- 免疫学 免疫学 免疫学
背景情况:
- IgA脏病 (IgAN) 是一种常见的初级血球炎.
- 足细胞损伤是IgAN进展和功能下降的关键因素.
- 需要新的生物标志物来预测Igan的预后.
研究的目的:
- 为了研究尿路cofilin-1和Igan患者的功能之间的相关性.
- 探索cofilin-1在IGAN中对脏不良预后的预测价值.
- 在IGAN中评估cofilin-1作为受细胞损伤的生物标志物.
主要方法:
- 133名Igan患者的前性队列研究.
- 使用ELISA测量尿中的cofilin-1,Rhoa和NGAL.
- 收集基线临床病理学数据和至少6个月的随访.
- 用于相关性分析的物流和考克斯回归模型.
主要成果:
- 尿中可菲林-1的增加与基线功能下降独立相关 (eGFR <60毫升/分钟/1.73米2).
- 在IgAN患者中,尿中的cofilin-1水平预测了脏不良预后 (AUC = 0.803).
- 科菲林-1在诊断功能下降方面表现出有效性 (AUC = 0.708).
结论:
- 泌尿中的cofilin-1是一种新的生物标志物,与Igan的功能下降密切相关.
- 科菲林-1在IgAN中具有临床价值,可以预测脏不良预后的风险.
- 由cofilin-1表示的足细胞损伤会影响Igan的结果.
相关概念视频
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

